TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/23 15:50 | 12/1/23 | NKGN | Nkgen Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Graf James A | CA | O | Interim | P.m | 2 | 3.24 | 0 | 1 | 0 | 2,437 | D | ||||||||||||||
11/22/23 17:55 | 11/20/23 | NKGN | Nkgen Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Graf James A | CA | O | Interim | P.m | 0 | 2.93 | 0 | 0 | 0 | 2,437 | D | ||||||||||||||
6/3/21 06:03 | 5/28/21 | GFOR | Graf Acquisition Corp. IV | DE | Financ | AcqCo | Blank Checks | Graf James A | TX | O | CEO | P.m | 50 | 9.90 | 0 | 5 | 0 | 4,237 | D | ||||||||||||||
5/27/21 16:57 | 5/25/21 | GFOR | Graf Acquisition Corp. IV | DE | Financ | AcqCo | Blank Checks | Graf James A | TX | O | CEO | P.m | 5 | 9.92 | 0 | 1 | 0 | 4,254 | D | ||||||||||||||
5/25/21 19:45 | 5/21/21 | GFOR | Graf Acquisition Corp. IV | DE | Financ | AcqCo | Blank Checks | Graf James A | TX | O | CEO | P.m | 13 | 9.94 | 0 | 1 | 0 | 8,506 | D | ||||||||||||||
3/1/19 19:21 | 2/27/19 | EAGL | Platinum Eagle Acquisition Corp. | PerSv | Hotel | Hotels, Rooming Houses, Camps | Graf James A | CA | D | P | 10 | 10.14 | 0 | 1 | New | 1 | D | ||||||||||||||||
5/8/12 14:32 | 5/8/12 | EAGL | Global Eagle Acquisition Corp. | DE | Financ | AcqCo | Blank Checks | Graf James A | CA | O | CFO,VP,T | P | 0 | 0.0113 | 0 | 0 | 0 | 165 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |